JamesFDoyleMBKwokM. Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis. Mayo Clin Proc. 2009;84:234-242.
2.
PulipakaULacomisDOmaluB. Amiodarone-induced neuromyopathy: three cases and a review of the literature. J Clin Neuromuscul Dis. 2002;3:97-105.
3.
CloustonPDDonnellyPE. Acute necrotising myopathy associated with amiodarone therapy. Aust N Z J Med. 1989;19:483-485.
4.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
5.
SandeepAS. Severe muscle cramps after intravenous administration of amiodarone: a novel, potentially, dose-dependent adverse effect. Br J Clin Pharmacol. 2011;71:624-625.
6.
BlascoLM. Trepopnea due to amiodarone induced diffuse alveolar haemorrhage. Respir Care. 2013;58:e11-e13.
